Our analyses reveal that AMs from both mouse models of lung cancer and human NSCLC patients exhibit similar enrichment of glycolytic and non-canonical TCA cycle gene signatures, alongside reduced SOCS3 secretion (15). The gene discussed is SOCS3; the disease is non-small cell lung carcinoma.